Nishi Patel

Heart disease continues to be one of the most pressing public health concerns in the United States and around the world. Despite decades of medical progress, cardiovascular conditions such as coronary artery disease, heart failure, and arrhythmias remain the leading causes of death. Early identification of individuals at high risk is critical, yet traditional screening methods often rely on generalized models that do not fully account for individual differences. As healthcare becomes more data-driven, Artificial Intelligence (AI) is playing an increasingly central role in reshaping how cardiac risk is predicted and managed. AI refers to computer systems designed to perform tasks that typically require human intelligence , including pattern recognition, prediction, and decision-making. In cardiology, AI tools analyze vast amounts of medical data—from electronic health records to imaging scans and wearable device readings—to identify subtle risk factors and trends. By uncovering patterns...

Cardiovascular diseases remain one of the leading causes of death worldwide , but not all heart conditions are the same. While some arise primarily from lifestyle factors such as poor diet, lack of exercise, or smoking, others are deeply rooted in genetics. Complex cardiovascular conditions often involve multiple genes interacting with environmental triggers, making diagnosis and treatment particularly challenging. These conditions may include inherited cardiomyopathies, arrhythmias, congenital heart defects, and familial hypercholesterolemia. In many cases, patients present with symptoms that do not fit the typical profile of common heart disease. For example, a young, physically active individual may experience sudden cardiac arrest without prior warning. Situations like this highlight the importance of understanding genetic influences. Genetic testing has emerged as a powerful diagnostic and preventive tool in cardiology. By analyzing an individual’s DNA, healthcare providers can id...

Advanced cardiac arrhythmias represent some of the most life-threatening conditions in cardiovascular medicine. While many rhythm disturbances are transient and clinically insignificant, others can abruptly compromise cardiac output and lead to sudden cardiac arrest. These high-risk arrhythmias, particularly ventricular tachycardia and ventricular fibrillation, disrupt coordinated myocardial contraction and may result in collapse within moments. Over time, cardiology has shifted from reactive emergency response to proactive risk identification and device-based prevention. Innovations in cardiac electrophysiology, implantable technologies , and remote monitoring systems have dramatically improved survival rates among high-risk populations. Today, early detection and appropriately deployed device therapies stand at the center of strategies aimed at preventing sudden cardiac death. The Electrophysiologic Basis of Malignant Arrhythmias Advanced arrhythmias arise from disturbances in the ca...

Cardiovascular disease remains one of the leading causes of morbidity and mortality worldwide, and diagnosing complex cardiac conditions continues to challenge clinicians. Traditional tools such as electrocardiography, standard echocardiography, and invasive angiography have long formed the backbone of cardiac evaluation. However, as patient presentations become more intricate and comorbidities more common, the demand for more precise, noninvasive, and data-rich imaging techniques has grown significantly. Emerging imaging technologies in cardiology are transforming how physicians evaluate structure, function, perfusion, and tissue characteristics of the heart. From advanced cardiac MRI to artificial intelligence-driven image analysis, these innovations are enabling earlier detection, more accurate risk stratification, and better treatment planning. The following sections explore six key areas reshaping complex cardiac diagnosis. Advanced Cardiac Magnetic Resonance Imaging Cardiac ma...